Literature DB >> 14010647

Study of the antigenic structure of tumors.

G I ABELEV.   

Abstract

Entities:  

Keywords:  ANTIGENS; HEPATOMA

Mesh:

Substances:

Year:  1963        PMID: 14010647

Source DB:  PubMed          Journal:  Acta Unio Int Contra Cancrum        ISSN: 0365-3056


× No keyword cloud information.
  9 in total

1.  A tumor-associated antigen in human nephroblastomas.

Authors:  P Burtin; M C Gendron
Journal:  Proc Natl Acad Sci U S A       Date:  1973-07       Impact factor: 11.205

2.  Relationship between embryonic and tumor lipids. I. Changes in the neutral lipids of the developing chick brain, heart and liver.

Authors:  R Wood
Journal:  Lipids       Date:  1972-09       Impact factor: 1.880

3.  Cytotoxic effect of a xenogeneic antiserum on bone marrow cells from normal or sublethally irradiated ice.

Authors:  J Haot; E Möller; K Hiesche; L Révész
Journal:  Experientia       Date:  1972-08-15

4.  Progress in tropical pathology with special reference to Nigeria.

Authors:  G M Edington
Journal:  J Natl Med Assoc       Date:  1971-05       Impact factor: 1.798

Review 5.  Alpha-fetoprotein in primary liver cancer and other diseases.

Authors:  M Kew
Journal:  Gut       Date:  1974-10       Impact factor: 23.059

6.  Antigenic study of unfertilized mouse eggs: cross reactivity with SV40-induced antigens.

Authors:  W Baranska; P Koldovsky; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1970-09       Impact factor: 11.205

7.  Differences between human and mouse alpha-fetoprotein expression during early development.

Authors:  E A Jones; M Clement-Jones; O F James; D I Wilson
Journal:  J Anat       Date:  2001-05       Impact factor: 2.610

8.  Bioglycans and natural glycosides as a promising research topic in bioorganic chemistriy.

Authors:  Yu S Ovodov
Journal:  Acta Naturae       Date:  2010-07       Impact factor: 1.845

9.  Specific carcinoembryonic antigens of the human digestive system.

Authors:  P Gold; S O Freedman
Journal:  J Exp Med       Date:  1965-09-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.